2
项与 非格司亭生物类似药(CuraTeQ) 相关的临床试验A randomized, phase 1, double-blind, single-period, two-treatment, parallel, Multiple dose, balanced, comparative pharmacokinetic, pharmacodynamic, safety and immunogenicity assessment of BP13 (Filgrastim) 300 mcg/0.5 ml PFS with US Licensed - NEUPOGEN® (filgrastim) 300 mcg/0.5 mL in a single-dose prefilled syringe in healthy adult male Subjects - NIL
A Double-Blind, Randomized, Parallel, Controlled, Study to Compare Pharmacokinetics and Pharmacodynamics of BP13 (filgrastim) with EU-approved Neupogen® in Healthy Male Adult Subjects
100 项与 非格司亭生物类似药(CuraTeQ) 相关的临床结果
100 项与 非格司亭生物类似药(CuraTeQ) 相关的转化医学
100 项与 非格司亭生物类似药(CuraTeQ) 相关的专利(医药)
100 项与 非格司亭生物类似药(CuraTeQ) 相关的药物交易